A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy
Author:
Funder
Ministry of University and Research PRIN 2005
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/20/7/1193/982648/mdn761.pdf
Reference23 articles.
1. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18;Fisher;J Clin Oncol,1997
2. Clinical course of breast cancer patients with complete pathological tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy;Kuerer;J Clin Oncol,1999
3. Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors;Guarneri;J Clin Oncol,2006
4. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes;Rouzier;J Clin Oncol,2002
5. Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy;Hennessy;J Clin Oncol,2005
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluation of the Pathological Complete Response (pCR) as a Surrogate Endpoint of Neoadjuvant Chemotherapy: Real-World Evidence;2024-01-12
2. “Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”;Breast Cancer: Targets and Therapy;2023-07
3. The potential of Senicapoc, a KCNN4 inhibitor, for the prevention and treatment of breast cancer;2023-04-28
4. Impact of residual disease biomarkers on the prognosis of HER2‐positive breast cancer following neoadjuvant therapy;Cancer Medicine;2023-03-23
5. Postneoadjuvant treatment for triple-negative breast cancer;Current Opinion in Oncology;2022-08-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3